340 related articles for article (PubMed ID: 10971451)
1. Expression analysis of cyclins in pituitary adenomas and the normal pituitary gland.
Turner HE; Nagy Z; Sullivan N; Esiri MM; Wass JA
Clin Endocrinol (Oxf); 2000 Sep; 53(3):337-44. PubMed ID: 10971451
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D and cyclin E expression in normal and adenomatous pituitary.
Jordan S; Lidhar K; Korbonits M; Lowe DG; Grossman AB
Eur J Endocrinol; 2000 Jul; 143(1):R1-6. PubMed ID: 10870044
[TBL] [Abstract][Full Text] [Related]
3. Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour.
Turner HE; Nagy Z; Gatter KC; Esiri MM; Wass JA; Harris AL
Br J Cancer; 2000 Apr; 82(8):1441-5. PubMed ID: 10780524
[TBL] [Abstract][Full Text] [Related]
4. Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness.
Shimon I; Hinton DR; Weiss MH; Melmed S
Clin Endocrinol (Oxf); 1998 Jan; 48(1):23-9. PubMed ID: 9509064
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of p27 (Kip1) in human pituitary glands and in various types of pituitary adenomas.
Komatsubara K; Tahara S; Umeoka K; Sanno N; Teramoto A; Osamura RY
Endocr Pathol; 2001; 12(2):181-8. PubMed ID: 11579684
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
Kola B; Korbonits M; Diaz-Cano S; Kaltsas G; Morris DG; Jordan S; Metherell L; Powell M; Czirják S; Arnaldi G; Bustin S; Boscaro M; Mantero F; Grossman AB
Clin Endocrinol (Oxf); 2003 Sep; 59(3):328-38. PubMed ID: 12919156
[TBL] [Abstract][Full Text] [Related]
7. The release of leptin and its effect on hormone release from human pituitary adenomas.
Korbonits M; Chitnis MM; Gueorguiev M; Norman D; Rosenfelder N; Suliman M; Jones TH; Noonan K; Fabbri A; Besser GM; Burrin JM; Grossman AB
Clin Endocrinol (Oxf); 2001 Jun; 54(6):781-9. PubMed ID: 11422113
[TBL] [Abstract][Full Text] [Related]
8. Mdm2 and the p53 pathway in human pituitary adenomas.
Suliman M; Royds J; Cullen D; Timperley W; Powell T; Battersby R; Jones TH
Clin Endocrinol (Oxf); 2001 Mar; 54(3):317-25. PubMed ID: 11298083
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome.
Turner HE; Nagy Z; Gatter KC; Esiri MM; Harris AL; Wass JA
J Endocrinol; 2000 May; 165(2):475-81. PubMed ID: 10810311
[TBL] [Abstract][Full Text] [Related]
10. Cyclins D1 and D3 and topoisomerase II alpha in inactive pituitary adenomas.
Saeger W; Schreiber S; Lüdecke DK
Endocr Pathol; 2001; 12(1):39-47. PubMed ID: 11478267
[TBL] [Abstract][Full Text] [Related]
11. Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently.
Bradley KJ; Wass JA; Turner HE
Clin Endocrinol (Oxf); 2003 Jan; 58(1):59-64. PubMed ID: 12519413
[TBL] [Abstract][Full Text] [Related]
12. Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours.
Onofri C; Theodoropoulou M; Losa M; Uhl E; Lange M; Arzt E; Stalla GK; Renner U
J Endocrinol; 2006 Oct; 191(1):249-61. PubMed ID: 17065408
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of cyclin D1 in human pituitary tumors: relation to MIB-1 and p27/Kip1 labeling indices.
Hewedi IH; Osman WM; El Mahdy MM
J Egypt Natl Canc Inst; 2011 Dec; 23(4):171-9. PubMed ID: 22776845
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6, a growth promoting cytokine, is present in human pituitary adenomas: an immunocytochemical study.
Tsagarakis S; Kontogeorgos G; Giannou P; Thalassinos N; Woolley J; Besser GM; Grossman A
Clin Endocrinol (Oxf); 1992 Aug; 37(2):163-7. PubMed ID: 1327588
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle dysregulation in pituitary oncogenesis.
Muşat M; Vax VV; Borboli N; Gueorguiev M; Bonner S; Korbonits M; Grossman AB
Front Horm Res; 2004; 32():34-62. PubMed ID: 15281339
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas.
Simpson DJ; Fryer AA; Grossman AB; Wass JA; Pfeifer M; Kros JM; Clayton RN; Farrell WE
Carcinogenesis; 2001 Nov; 22(11):1801-7. PubMed ID: 11698342
[TBL] [Abstract][Full Text] [Related]
17. Glycoprotein hormone alpha-subunit production and plurihormonality in human corticotroph tumours--an in vitro and immunohistochemical study.
Desai B; Burrin JM; Nott CA; Geddes JF; Lamb EJ; Aylwin SJ; Wood DF; Thakkar C; Monson JP
Eur J Endocrinol; 1995 Jul; 133(1):25-32. PubMed ID: 7542980
[TBL] [Abstract][Full Text] [Related]
18. Lack of correlation between Ki-67 labelling index and tumor size of anterior pituitary adenomas.
Mastronardi L; Guiducci A; Puzzilli F
BMC Cancer; 2001; 1():12. PubMed ID: 11570981
[TBL] [Abstract][Full Text] [Related]
19. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
